Literature DB >> 3415294

Faecal chymotrypsin: a reliable index of exocrine pancreatic function.

G A Brown1, D Sule, J Williams, J W Puntis, I W Booth, A S McNeish.   

Abstract

Simultaneous measurements of duodenal and faecal chymotrypsin were made in 30 children aged 3 weeks to 14 years. Apparent chymotrypsin secretion rates measured after stimulation with pancreozymin were compared with the mean faecal chymotrypsin concentration derived from three stool specimens collected at random within 72 hours of the intraduodenal test. In the 25 children who responded to pancreozymin stimulation the mean faecal chymotrypsin concentration was significantly positively correlated with the apparent chymotrypsin secretion rate. Correlation using single specimen stools collected at random was appreciably poorer. In the five children with undetectable or only traces of chymotrypsin in the duodenum after stimulation, the mean faecal chymotrypsin concentrations were only 3-10% of the lower limit of the reference interval. In a second group of 46 children with cystic fibrosis proved by sweat tests and clinical evidence of malabsorption, the chymotrypsin concentration measured in a single stool specimen collected at random was unequivocally subnormal in each case. Faecal chymotrypsin measurement is a rapid, simple, cheap, readily repeated, non-invasive test of high specificity and sensitivity. Faecal chymotrypsin should be measured before contemplating intraduodenal tests of pancreatic function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3415294      PMCID: PMC1779069          DOI: 10.1136/adc.63.7.785

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  Fate of pancreatic enzymes during small intestinal aboral transit in humans.

Authors:  P Layer; V L Go; E P DiMagno
Journal:  Am J Physiol       Date:  1986-10

2.  Diagnosis of pancreatic exocrine insufficiency by fecal chymotrypsin activity.

Authors:  D D Moeller; G D Dunn; A P Klotz
Journal:  Am J Dig Dis       Date:  1973-09

3.  Trypsin and chymotrypsin in duodenal aspirate and faeces in response to secretin and cholecystokinin-pancreozymin.

Authors:  J K Sale; D M Goldberg; B Thjodleifsson; K G Wormsley
Journal:  Gut       Date:  1974-02       Impact factor: 23.059

4.  Effect of light exposure on gut transit time in jaundiced newborns.

Authors:  F F Rubaltelli; G Largajolli
Journal:  Acta Paediatr Scand       Date:  1973-03

5.  Fecal chymotrypsin: a new diagnostic test for exocrine pancreatic insufficiency in children with cystic fibrosis.

Authors:  M S Scotta; M D Marzani; G Maggiore; C De Giacomo; G V Melzi D'Eril; R Moratti
Journal:  Clin Biochem       Date:  1985-08       Impact factor: 3.281

6.  The distribution of chymotrypsin within the feces and description of a new device for the preparation of stool samples.

Authors:  P Kaspar; U Neumann
Journal:  Clin Chem       Date:  1984-11       Impact factor: 8.327

7.  Stool trypsin and chymotrypsin. Value in the diagnosis of pancreatic insufficiency in cystic fibrosis.

Authors:  G J Barbero; M S Sibinga; J M Marino; R Seibel
Journal:  Am J Dis Child       Date:  1966-12

8.  Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns.

Authors:  P A Cann; N W Read; C Brown; N Hobson; C D Holdsworth
Journal:  Gut       Date:  1983-05       Impact factor: 23.059

9.  A single-specimen fecal chymotrypsin test in the diagnosis of pancreatic insufficiency: correlation with secretin-cholecystokinin and NBT-PABA tests.

Authors:  F Lami; C Callegari; M Miglioli; L Barbara
Journal:  Am J Gastroenterol       Date:  1984-09       Impact factor: 10.864

10.  Fecal chymotroypsin: a study on its diagnostic value by comparison with the secretin-cholecystokinin test.

Authors:  H K Dürr; M Otte; M M Forell; J C Bode
Journal:  Digestion       Date:  1978       Impact factor: 3.216

View more
  15 in total

Review 1.  Control of malabsorption in cystic fibrosis.

Authors:  J M Littlewood; S P Wolfe
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

2.  Guidelines for the investigation of chronic diarrhoea, 2nd edition.

Authors:  P D Thomas; A Forbes; J Green; P Howdle; R Long; R Playford; M Sheridan; R Stevens; R Valori; J Walters; G M Addison; P Hill; G Brydon
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

3.  Two enteric coated microspheres in cystic fibrosis.

Authors:  J Williams; A MacDonald; P H Weller; J Fields; H Pandov
Journal:  Arch Dis Child       Date:  1990-06       Impact factor: 3.791

4.  Improving care for central nervous system tumours: a mood for change.

Authors:  L S Lashford; D A Walker
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

Review 5.  Diagnosing cystic fibrosis: blood, sweat, and tears.

Authors:  C Wallis
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

6.  Ontogeny of pancreatic exocrine function.

Authors:  S Kolacek; J W Puntis; D R Lloyd; G A Brown; I W Booth
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

7.  Faecal chymotrypsin in small for gestational age infants: effects of nucleotides and breast feeding.

Authors:  M Cosgrove; H Losty; H R Jenkins; D P Davies
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-05       Impact factor: 5.747

8.  Faecal chymotrypsin concentrations in neonates with cystic fibrosis and healthy controls.

Authors:  G A Brown; R B Halliday; P J Turner; C A Smalley
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

Review 9.  Nutritional management of the infant with cystic fibrosis.

Authors:  M R Green; E Buchanan; L T Weaver
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

10.  Dual marker one day pancreolauryl test.

Authors:  M R Green; S Austin; L T Weaver
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.